Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Topics in Hospital Pharmacy Management
|
July 8, 1990
Outcome assessment of pain: functional status measures and quality of life as therapeutic endpoints
C A Sorkness
Pharmacotherapy
|
January 1, 1997
The use of 5-lipoxygenase inhibitors and leukotriene receptor antagonists in the treatment of chronic asthma
C A Sorkness
The Journal of Allergy and Clinical Immunology
|
November 3, 1998
Establishing a therapeutic index for the inhaled corticosteroids: part II. Comparisons of systemic activity and safety among different inhaled corticosteroids
C A Sorkness
Pharmacotherapy
|
March 20, 2001
Leukotriene receptor antagonists in the treatment of asthma
C A Sorkness
Expert Opinion on Pharmacotherapy
|
March 16, 2001
Fluticasone propionate: a potent inhaled corticosteroid for the treatment of asthma
A G Staresinic, C A Sorkness
Journal of Pain and Symptom Management
|
January 1, 1987
Issues in drug management. Part I. Antidepressants and chronic nonmalignant pain: a review
C J Getto, C A Sorkness, T Howell
Controlled Clinical Trials
|
December 1, 2001
Recruitment strategies in the Asthma Clinical Research Network
C A Sorkness, J G Ford, R F Lemanske, et al.
The Annals of Pharmacotherapy
|
December 1, 1996
Potential interaction between warfarin and dicloxacillin
A T Mailloux, B E Gidal, C A Sorkness
Clinical Pharmacy
|
January 1, 1985
Analgesia with oral narcotics and added ibuprofen in cancer patients
W A Weingart, C A Sorkness, R H Earhart
American Journal of Hospital Pharmacy
|
July 1, 1985
Use of serum drug concentrations in outpatient clinics
M E Pitterle, C A Sorkness, J B Wiederholt
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Topics in Hospital Pharmacy Management
|
July 8, 1990
Outcome assessment of pain: functional status measures and quality of life as therapeutic endpoints
C A Sorkness
Pharmacotherapy
|
January 1, 1997
The use of 5-lipoxygenase inhibitors and leukotriene receptor antagonists in the treatment of chronic asthma
C A Sorkness
The Journal of Allergy and Clinical Immunology
|
November 3, 1998
Establishing a therapeutic index for the inhaled corticosteroids: part II. Comparisons of systemic activity and safety among different inhaled corticosteroids
C A Sorkness
Pharmacotherapy
|
March 20, 2001
Leukotriene receptor antagonists in the treatment of asthma
C A Sorkness
Expert Opinion on Pharmacotherapy
|
March 16, 2001
Fluticasone propionate: a potent inhaled corticosteroid for the treatment of asthma
A G Staresinic, C A Sorkness
Journal of Pain and Symptom Management
|
January 1, 1987
Issues in drug management. Part I. Antidepressants and chronic nonmalignant pain: a review
C J Getto, C A Sorkness, T Howell
Controlled Clinical Trials
|
December 1, 2001
Recruitment strategies in the Asthma Clinical Research Network
C A Sorkness, J G Ford, R F Lemanske, et al.
The Annals of Pharmacotherapy
|
December 1, 1996
Potential interaction between warfarin and dicloxacillin
A T Mailloux, B E Gidal, C A Sorkness
Clinical Pharmacy
|
January 1, 1985
Analgesia with oral narcotics and added ibuprofen in cancer patients
W A Weingart, C A Sorkness, R H Earhart
American Journal of Hospital Pharmacy
|
July 1, 1985
Use of serum drug concentrations in outpatient clinics
M E Pitterle, C A Sorkness, J B Wiederholt
Page
of 3